Radiation dose rates from patients undergoing PET: implications for technologists and waiting areas

被引:76
作者
Benatar, NA [1 ]
Cronin, BF [1 ]
O'Doherty, MJ [1 ]
机构
[1] Guys & St Thomas Hosp, Clin PET Ctr, London SE1 7EH, England
关键词
fluorodeoxyglucose; positron emission tomography; radiation protection;
D O I
10.1007/s002590050546
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Increasingly hospitals are showing an interest in developing their imaging services to include positron emission tomography (PET). There is therefore a need to be aware of the radiation doses to critical groups. To assess the effective whole-body dose received by technologists within our dedicated PET centre, each staff member was issued with a dose rate meter; and was instructed to record the time spent in contact with any radioactive source, the dose received per working day and the daily injected activity. On average each technologist administered 831 MBq per day. The mean whole-body dose per MBq injected was 0.02 mu Sv/MBq(-1). The average time of close contact (<2.0 m) with a radioactive source per day was 32 min. The average effective dose per minute close contact was 0.5 mu Sv/min(-1), which resulted in a mean daily effective dose of 14.4 mu Sv. No technologist received greater than 60 mu Sv (the current UK limit for non-classified workers) in any one day, and in general doses received were less than 24 mu Sv, the daily dose corresponding to the proposed new annual limit for non-classified workers of 6.0 mSv pel annum. However, we recognise that the layout of nuclear medicine departments will not mirror our own. We therefore measured the instantaneous dose rates at 0.1, 0.5, 1.0 and 2.0 m from the mid-thorax on 115 patients immediately after injection, to provide estimates of the likely effective doses that might be received by technologists operating dual-headed coincidence detection systems, and others coming into contact in the waiting room with patients who have been injected with fluorine-18 fluorodeoxyglucose. The mean (95th percentile) dose rates measured at the four aforementioned distances were 391.7 (549.5), 127.0 (199.8), 45.3 (70.0) and 17.1 (30.0) mu Sv/h(-1), respectively. A number of situations have been modelled showing that, with correct planning, FDG studies should not significantly increase the effective doses to technologists. However, one possible area of concern is that, depending on the number of patients in a waiting area at any one time, accompanying pel sons may approach the limits set by the new UK IRR 1999 regulations for members of the public.
引用
收藏
页码:583 / 589
页数:7
相关论文
共 16 条
[1]   ECAT ART - A continuously rotating PET camera: Performance characteristics, initial clinical studies, and installation considerations in a nuclear medicine department [J].
Bailey, DL ;
Young, H ;
Bloomfield, PM ;
Meikle, SR ;
Glass, D ;
Myers, MJ ;
Spinks, TJ ;
Watson, CC ;
Luk, P ;
Peters, AM ;
Jones, T .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (01) :6-15
[2]   Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer [J].
Boerner, AR ;
Weckesser, M ;
Herzog, H ;
Schmitz, T ;
Audretsch, W ;
Nitz, U ;
Bender, HG ;
Mueller-Gaertner, HW .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (03) :226-230
[3]   Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose [J].
Chiesa, C ;
DeSanctis, V ;
Crippa, F ;
Schiavini, M ;
Fraigola, CE ;
Bogni, A ;
Pascali, C ;
Decise, D ;
Marchesini, R ;
Bombardieri, E .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (11) :1380-1389
[4]   RADIATION-DOSES FROM NUCLEAR-MEDICINE PATIENTS TO AN IMAGING TECHNOLOGIST - RELATION TO ICRP RECOMMENDATIONS FOR PREGNANT WORKERS [J].
CLARKE, EA ;
THOMSON, WH ;
NOTGHI, A ;
HARDING, LK .
NUCLEAR MEDICINE COMMUNICATIONS, 1992, 13 (11) :795-798
[5]   Are MIBI/tetrofosmin heart studies a potential radiation hazard to technologists? [J].
Clarke, EA ;
Notghi, A ;
Harding, LK .
NUCLEAR MEDICINE COMMUNICATIONS, 1997, 18 (06) :574-577
[6]  
Council of the European Union, 1996, OFFICIAL J L, VL159, P1
[7]   Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies? [J].
Cronin, B ;
Marsden, PK ;
O'Doherty, MJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (02) :121-128
[8]  
CULVER CM, 1993, J NUCL MED, V34, P1210
[9]   RADIATION-DOSES TO STAFF IN A DEPARTMENT OF NUCLEAR-MEDICINE [J].
HARBOTTLE, EA ;
PARKER, RP ;
DAVIS, R .
BRITISH JOURNAL OF RADIOLOGY, 1976, 49 (583) :612-617
[10]  
HARDING LK, 1994, EUR J NUCL MED, V21, P1223